Study flow chart.

<p>Study flow chart.</p

Cervical intraepithelial neoplasia grade 2 across continents.

<p>Cervical intraepithelial neoplasia grade 2 across continents.</p

Cervical adenocarcinoma and adenosquamous cell carcinoma across continents.

<p>Cervical adenocarcinoma and adenosquamous cell carcinoma across continents.</p

Prevalence and attribution of HPV52 and HPV58 across different lesion grades in Eastern Asia and other parts of the world.

1<p>Relative prevalence, no. of HPV52-positive cases regardless of single- or multiple-type infection/total no. of HPV-positive cases.</p>2<p>% of cases with HPV52 single-type infection +% of cases with HPV52 multiple-type infection × attribution factor. Attribution factor  =  no. of cases with HPV52 single-type infection/no. of cases with single-type infection of any HPV type.</p>3<p>Relative prevalence, no. of HPV58-positive cases regardless of single- or multiple-type infection/total no. of HPV-positive cases.</p>4<p>% of cases with HPV58 single-type infection +% of cases with HPV58 multiple-type infection × attribution factor. Attribution factor  =  no. of cases with HPV58 single-type infection/no. of cases with single-type infection of any HPV type.</p><p>CIN, cervical intraepithelial neoplasia; SCC/UNSPEC, squamous cell carcinomas and invasive cervical cancers of unspecified histology; adenocarcinoma includes cervical adenocarcinoma and adenosquamous cell carcinoma.</p><p>Prevalence and attribution of HPV52 and HPV58 across different lesion grades in Eastern Asia and other parts of the world.</p

Prevalence and attribution of HPV52 and HPV58 among cervical lesions in Eastern Asia.

<p>Prevalence and attribution of HPV52 and HPV58 among cervical lesions in Eastern Asia.</p